The NHS Health Check in England: An evaluation of the first 4 years

BMJ Open

Volumn 6, Issue 1, 2016, Pages

  Robson, John ^a   Dostal, Isabel ^a   Sheikh, Aziz ^b   Eldridge, Sandra ^a   Madurasinghe, Vichithranie ^a   Griffiths, Chris ^a   Coupland, Carol ^c   Hippisley Cox, Julia ^c  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; ARTICLE; BEHAVIOR CHANGE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; COMORBIDITY; EVALUATION STUDY; FEMALE; GENERAL PRACTICE; HEALTH CARE PLANNING; HEALTH PROGRAM; HEALTH SURVEY; HIGH RISK POPULATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NATIONAL HEALTH SERVICE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATIONAL STUDY; PREVENTIVE HEALTH SERVICE; UNITED KINGDOM; AGE DISTRIBUTION; CARDIOVASCULAR DISEASES; EARLY DIAGNOSIS; ENGLAND; HEALTH PROMOTION; MIDDLE AGED; PROCEDURES; RISK ASSESSMENT; SEX RATIO; SOCIOECONOMICS;

ADULT; AGE DISTRIBUTION; AGED; CARDIOVASCULAR DISEASES; EARLY DIAGNOSIS; ENGLAND; FEMALE; GENERAL PRACTICE; HEALTH PROMOTION; HUMANS; MALE; MIDDLE AGED; RISK ASSESSMENT; SEX DISTRIBUTION; SOCIOECONOMIC FACTORS; STATE MEDICINE;

EID: 84960332961     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2015-008840     Document Type: Article

References (66)

1. Public Health England. NHS Health Check programme standards. NHS England, 2014. http://www.healthcheck.nhs.uk/commissioners- and-healthcare-professionals/national-guidance/(accessed 12 Mar 2015).
2. Kerr M. NHS Health Check costs, benefits and savings. Department of Health, 2012. http://www.nhshealthcheck.nhs.uk/default.aspx? aID=18 (accessed 12 Mar 2015).
3. Public Health England. NHS Health Check programme best practice guidance, 2013. http://www.healthcheck.nhs.uk/commissioners- and-healthcare-professionals/national-guidance/(accessed 12 Mar 2015).
4. Department of Health. NHS Health Checks 2011-13, 2013. http://www.england.nhs.uk/statistics/integrated-performance-measuresmonitoring/nhs-health-checks-data/(accessed 12 Mar 2015).
5. Nicholas JM, Burgess C, Dodhia H, et al. Variations in the organization and delivery of the 'NHS health check' in primary care. J Public Health (Oxf) 2013;35:85-91.
6. Artac M, Dalton AR, Babu H, et al. Primary care and population factors associated with NHS Health Check coverage: A national cross-sectional study. J Public Health (Oxf) 2013;35:431-9.
7. Department of Health. Living well for longer: A call to action on avoiding premature mortality. London, 2013.
8. Department of Health. Improving outcomes for people with or at risk of cardiovascular disease. London, 2013. https://www.gov.uk/government/publications/cardiovascular-disease-outcomes-strategyimproving-outcomes-for-people-with-or-at-risk-ofcardiovascular-disease (accessed 12 Mar 2015).
9. Department of Health. Putting prevention first: NHS Health check: Vascular risk assessment and management. Best practice guidance. London, 2009. http://www.healthcheck.nhs.uk/document.php?o=227 (accessed 12 Mar 2015).
10. NICE. Lipid modification: Cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease. CG67. London: National Institute of Health and Clinical Excellence, 2008.
11. Mihaylova B, Emberson J, Blackwell L, et al, Cholesterol Treatment Trialists (CTT) Collaborators. The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: Meta-analysis of individual data from 27 randomised trials. Lancet 2012;380:581-90.
12. Taylor F, Huffman MD, Macedo AF, et al. Statins for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev 2013;(1):CD004816.
13. Czernichow S, Zanchetti A, Turnbull F, et al. The effects of blood pressure reduction and of different blood pressure-lowering regimens on major cardiovascular events according to baseline blood pressure: Meta-analysis of randomized trials. J Hypertens 2011;29:4-16.
14. Baigent C, Keech A, Kearney PM, et al. Efficacy and safety of cholesterol-lowering treatment: Prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 2005;366:1267-78.
15. Jackson R, Wells S, Rodgers A. Will screening individuals at high risk of cardiovascular events deliver large benefits? Yes. BMJ 2008;337:a1371.
16. Capewell S, Lloyd-Jones DM. Optimal cardiovascular prevention strategies for the 21st century. JAMA 2010;304:2057-8.
17. Ebrahim S, Taylor F, Ward K, et al. Multiple risk factor interventions for primary prevention of coronary heart disease. Cochrane Database Syst Rev 2011;(1):CD001561.
18. Berger JS, Jordan CO, Lloyd-Jones D, et al. Screening for cardiovascular risk in asymptomatic patients. J Am Coll Cardiol 2010;55:1169-77.
19. Mehta S, Wells S, Grey C, et al. Initiation and maintenance of cardiovascular medications following cardiovascular risk assessment in a large primary care cohort: PREDICT CVD-16. Eur J Prev Cardiol 2014;21:192-202.
20. Ioannidis JP. More than a billion people taking statins? Potential implications of the new cardiovascular guidelines. JAMA 2014;311:463-4.
21. von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies. J Clin Epidemiol 2008;61:344-9.
22. Health and Social Care Information Centre. NHS Health Check secondary use dataset, 2014. http://www.hscic.gov.uk/nhshealthcheck (accessed 13 Mar 2014).
23. Office of National Statistics. Presentation of ethnic group data, 2015. http://www.ons.gov.uk/ons/guide-method/measuring-equality/equality/ethnic-nat-identity-religion/ethnic-group/presentation-of-ethnic-group-data.html (accessed 28 Aug 2015).
24. Townsend P, Phillimore P, Beattie A. Health and Deprivation: Inequality and the North. London: Croom Helm, 1988.
25. Robson J, Dostal I, Madurasinghe V, et al. The NHS Health Check programme: Implementation in east London 2009-2011. BMJ Open 2015;5:e007578.
26. NICE. Lipid modification: Cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease. CG181. London: National Institute for Health and Care Excellence, 2014.
27. Sheikh A, Nurmatov UB, Cresswell K, et al. Investigating the cost-effectiveness of health information technologies: A systematic review protocol. BMJ Open 2013;3:e003737.
28. Hippisley-Cox J, Coupland C, Vinogradova Y, et al. Predicting cardiovascular risk in England and Wales: Prospective derivation and validation of QRISK2. BMJ 2008;336:1475-82.
29. Wells S, Furness S, Rafter N, et al. Integrated electronic decision support increases cardiovascular disease risk assessment four fold in routine primary care practice. Eur J Cardiovasc Prev Rehabil 2008;15:173-8.
30. Coffey C, Cooper AM, Brown T, et al. Vascular health checks in Salford. Manchester: University of Salford, 2014. http://usir. salford.ac.uk/35581/1/final-farsite-report.pdf (accessed 20 Aug 2015).
31. Chipchase L. An insight into the NHS health Check programme in Birmingham: NHS Health Checks national learning network, 2012. http://www.nhshealthcheck.nhs.uk/default.aspx?aID=45 (accessed 13 Mar 2014).
32. Hill S, Spink J, Cadilhac D, et al. Absolute risk representation in cardiovascular disease prevention: Comprehension and preferences of health care consumers and general practitioners involved in a focus group study. BMC Public Health 2010;10:108.
33. Liew SM, Blacklock C, Hislop J, et al. Cardiovascular risk scores: Qualitative study of how primary care practitioners understand and use them. Br J Gen Pract 2013;63:e401-7.
34. Krska J, du Plessis R, Chellaswamy H. Views and experiences of the NHS Health Check provided by general medical practices: Cross-sectional survey in high-risk patients. J Public Health (Oxf) 2015;37:210-17.
35. Artac M, Dalton AR, Majeed A, et al. Effectiveness of a national cardiovascular disease risk assessment program (NHS Health Check): Results after one year. Prev Med 2013;57:129-34.
36. Smith S, Waterall J, Burden AC. An evaluation of the performance of the NHS Health Check programme in identifying people at high risk of developing type 2 diabetes. BMJ Open 2013;3:pii: E002219..
37. Van Staa TP, Smeeth L, Ng ES, et al. The efficiency of cardiovascular risk assessment: Do the right patients get statin treatment? Heart 2013;99:7.
38. Prochazka AV, Lundahl K, Pearson W, et al. Support of evidence-based guidelines for the annual physical examination: A survey of primary care providers. Arch Intern Med 2005;165:1347-52.
39. Krogsboll LT, Jorgensen KJ, Gronhoj Larsen C, et al. General health checks in adults for reducing morbidity and mortality from disease: Cochrane systematic review and meta-analysis. BMJ 2012;345: E7191.
40. Krogsboll LT, Jørgensen KJ, Gøtzsche PC. Health checks. Letter to the editor. The Times 20/08/2013.
41. Krogsboll LT, Jorgensen KJ, Gotzsche PC. Universal health checks should be abandoned. BMJ 2013;347:f5227.
42. Shapiro S, Fink R, Rosenberg C. A program to measure the impact of multiphasic health testing on health differentials between poverty and nonpoverty groups. Med Care 1972;10:207-14.
43. Thorner RM, Djordjevic D, Vuckmanovic C, et al. A study to evaluate the effectiveness of multiphasic screening in Yugoslavia. Prev Med 1973;2:295-301.
44. South-East London Screening Study Group. A controlled trial of multiphasic screening in middle-age: Results of the South-East London Screening Study. The South-East London Screening Study Group. Int J Epidemiol 1977;6:357-63.
45. Bennett AE, Fraser IG. Impact of a screening programme in general practice: A randomized controlled trial. Int J Epidemiol 1972;1:55-60.
46. Tibblin G, Welin L, Larsson B, et al. The influence of repeated health examinations on mortality in a prospective cohort study, with a comment on the autopsy frequency. The study of men born in 1913. Scand J Soc Med 1982;10:27-32.
47. Lannerstad O, Sternby NH, Isacsson SO, et al. Effects of a health screening on mortality and causes of death in middle-aged men. A prospective study from 1970 to 1974 of mean in Malmo, born 1914. Scand J Soc Med 1977;5:137-40.
48. Olsen DM, Kane RL, Proctor PH. A controlled trial of multiphasic screening. N Engl J Med 1976;294:925-30.
49. Wilhelmsen L, Berglund G, Elmfeldt D, et al. The multifactor primary prevention trial in Goteborg, Sweden. Eur Heart J 1986;7:279-88.
50. Friedman GD, Collen MF, Fireman BH. Multiphasic health checkup evaluation: A 16-year follow-up. J Chronic Dis 1986;39:453-63.
51. World Health Organization European Collaborative Group. WHO European collaborative trial in the multifactorial prevention of coronary heart disease. WHO, 1989.
52. No authors listed]. Effectiveness of health checks conducted by nurses in primary care: Final results of the OXCHECK study. Imperial Cancer Research Fund OXCHECK Study Group. BMJ 1995;310:1099-104.
53. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344:1383-9.
54. Theobald H, Bygren LO, Carstensen J, et al. Effects of an assessment of needs for medical and social services on long-term mortality: A randomized controlled study. Int J Epidemiol 1998;27:194-8.
55. Jorgensen T, Borch-Johnsen K, Thomsen TF, et al. A randomized non-pharmacological intervention study for prevention of ischaemic heart disease: Baseline results Inter99. Eur J Cardiovasc Prev Rehabil 2003;10:377-86.
56. Thomsen JL, Parner ET, Karlsmose B, et al. Effect of preventive health screening on long-term primary health care utilization. A randomized controlled trial. Fam Pract 2005;22:242-8.
57. Jorgensen T, Jacobsen RK, Toft U, et al. Effect of screening and lifestyle counselling on incidence of ischaemic heart disease in general population: Inter99 randomised trial. BMJ 2014;348: G3617.
58. Daily Mail. Why statins might be pointless and even bad for you. 2008. http://www.dailymail.co.uk/health/article-1340299/Why-taking-statins-pointless-bad-you.html
59. Godlee F. Statins and the BMJ. BMJ 2014;349:g5038.
60. Collins R. Doctors fears over statins may cost lives. The Guardian 21/3/2014.
61. Appleby J. Is general practice in trouble? BMJ 2014;349:g6814.
62. Majeed A, Rawaf S, De Maeseneer J. Primary care in England: Coping with financial austerity. Br J Gen Pract 2012;62:625-6.
63. National Audit Office. Delivering efficiency savings in the NHS, 2011. http://www.nao.org.uk/wp-content/uploads/2011/12/NAO- briefing-Delivering-efficiency-savings-NHS.pdf (accessed 12 Mar 2015).
64. NHS England. NHS Health Checks Data, 2011. http://www.england. nhs.uk/statistics/statistical-work-areas/integrated-performancemeasures-monitoring/nhs-health-checks-data (accessed 12 Mar 2015).
65. Research Works Limited. Understanding the implementation of NHS Health Checks: Research Report: Public Health England, 2013. http://www.healthcheck.nhs.uk/document.php?o=351 (accessed 20 Feb 2014).
66. Public Health England. NHS Health Check implementation plan review and action plan, 2013. https://www.gov.uk/government/uploads/system/uploads/attachment-data/file/224805/NHS-Health- Check-implementation-review-and-action-plan.pdf (accessed 13 Mar 2015).